Rett Syndrome Completed Phase 3 Trials for Trofinetide (DB06045)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04181723Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)Treatment
NCT04279314Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeTreatment
NCT04776746Open-Label Extension Study of Trofinetide for Rett SyndromeTreatment